Search | Médecins Sans Frontières Access Campaign

12 results found

Feature story |

19 December 2012

Looking Ahead to 2013 with MSF's Dr Manica Balasegaram

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines HIV/AIDSneglected diseasestuberculosis vaccines research and development (R&D) Novartis Novartis Drop the Case Campaign

Video |

17 December 2012

Medicines Shouldn't be a Luxury

Medicines are essential for health and survival. But far too often, they’re priced like luxury items. We’re working to change that.

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDSneglected diseasestuberculosis research and development (R&D)

Events |

11 December 2012

Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDSneglected diseasessleeping sicknesstuberculosisvisceral leishmaniasis (kala azar) vaccines research and development (R&D)

Research article |

30 August 2012

New research and development strategy for tuberculosis diagnostics urgently needed

Tags HIV/AIDSResearch and developmentTuberculosis tuberculosisco-infectionHIV/AIDS diagnostic testsresearch and development (R&D)

Research article |

27 March 2011

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

Tags HIV/AIDSIntellectual property and trade HIV/AIDS patent poolresearch and development (R&D)

Feature story |

18 December 2007

A doctor's frustration

Tags HIV/AIDSTuberculosis HIV/AIDStuberculosis research and development (R&D) Kenya

Press release |

03 March 2007

MSF study shows good outcomes for second-line AIDS treatment in resource-poor settings

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicines diagnostic testsresearch and development (R&D)

Press release |

28 November 2005

Drug companies leave children with AIDS to fend for themselves

Tags HIV/AIDSResearch and development HIV/AIDS diagnostic testsresearch and development (R&D)

Events |

11 August 2005

Patient's needs driven Research and Development Agenda

Tags HIV/AIDS HIV/AIDS research and development (R&D)

Press release |

02 August 2005

Creative approach allows MSF to treat children with AIDS. But enormous challenges remain.

Tags HIV/AIDSResearch and development HIV/AIDS diagnostic testsresearch and development (R&D) International AIDS ConferenceWorld Health Organization

Press release |

08 June 2005

Global appeal for new treatments for neglected diseases launched

Tags HIV/AIDSResearch and developmentTropical & neglected diseasesTuberculosis HIV/AIDSsleeping sicknesstuberculosisvisceral leishmaniasis (kala azar) diagnostic testsresearch and development (R&D) DNDi

Press release |

30 November 2004

Access to AIDS Care Increasing at Snail’s Pace

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines research and development (R&D) Malawi

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Looking Ahead to 2013 with MSF's Dr Manica Balasegaram

Medicines Shouldn't be a Luxury

Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations

New research and development strategy for tuberculosis diagnostics urgently needed

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

A doctor's frustration

MSF study shows good outcomes for second-line AIDS treatment in resource-poor settings

Drug companies leave children with AIDS to fend for themselves

Patient's needs driven Research and Development Agenda

Creative approach allows MSF to treat children with AIDS. But enormous challenges remain.

Global appeal for new treatments for neglected diseases launched

Access to AIDS Care Increasing at Snail’s Pace